Daradia wins 11 abstract slots at IASP 2026 world pain congress

Daradia said seven affiliated researchers had 11 poster abstracts accepted for the 2026 IASP World Congress on Pain in Bangkok, covering nociplastic pain, cryoneurolysis, simulation training and pain medicine education. The accepted work adds visibility for the Kolkata pain clinic’s research program, though acceptance does not equal clinical proof or journal publication.

Why it matters: - Daradia’s presence at a major international pain meeting signals broader recognition for the clinic’s research in pain medicine education and interventional techniques. - The accepted abstracts span clinical research, validation work and training models, which can shape how pain specialists assess patients and teach procedures. - Acceptance into the congress program does not establish clinical effectiveness or peer-reviewed publication.

What happened: - Daradia reported that 11 poster abstracts involving seven affiliated authors were accepted into the scientific programme of the 21st World Congress on Pain. - The congress was organized by the International Association for the Study of Pain and held in Bangkok, Thailand, from 26 to 30 October 2026. - The accepted work involved Dr Smruti Rekha Hota, Dr Bindiya Devi Kangujam, Dr Sandeep Margan, Dr Anirudh Panemangalore Pai, Dr Sushpa Das, Dr Suzen Sumeet Kaur and Dr Gautam Das.

The details: - The abstracts covered nociplastic pain, image-guided cryoneurolysis, ultrasound-guided peripheral nerve interventions, simulation-based procedural training and artificial intelligence in pain medicine education. - One study evaluated the Daradia Nociplastic Pain Checklist in a prospective, blinded sample of 261 patients. - Another study tested a real-bone mannequin system for fluoroscopy-guided procedural training and included feedback from 108 participants. - Additional studies looked at outcomes after interventional pain procedures, physician awareness of nociplastic pain and educational approaches to persistent pain. - The accepted work included clinical case reports, retrospective observational studies, educational frameworks, surveys and validation research. - Daradia said Dr Sushpa Das and Dr Suzen Sumeet Kaur were unable to present in person for personal reasons. - Daradia published a research page with the abstract titles, authors, clinical summaries and direct links to the 11 original IASP abstract records for verification.

Between the lines: - The breadth of topics suggests Daradia is trying to position itself as both a treatment center and an academic contributor in pain medicine. - The mix of validation studies and education research points to a focus on tools, training and clinical decision-making, not only procedures. - Conference acceptance offers visibility, but the findings still need independent validation and peer-reviewed publication before they can be treated as established evidence.

What's next: - Daradia said it aims to pursue further evaluation of its findings through independent validation, collaboration and peer-reviewed publication. - The clinic’s broader research program will continue to focus on interventional pain procedures, pain assessment and physician education. - More information about the institution’s research is available through Daradia’s research and publications website.